An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said.
fda committeeFDA Panel Finds Tiotropium Safe for COPD PatientsMedPage Today Allergy & Immunology Fri, 11/20/2009 - 11:42
|
